Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Deep learning differentiates small renal masses on multiphase CT

A deep learning method with a convolutional neural network (CNN) can support the evaluation of small solid renal masses in dynamic CT images with acceptable diagnostic performance, according to an article published in the American Journal of Roentgenology (AJR).

Between 2012 and 2016, researchers at Japan's Okayama University studied 1807 image sets from 168 pathologically diagnosed small (≤4 cm) solid renal masses with four CT phases - unenhanced, corticomedullary, nephrogenic, and excretory in 159 patients.

Masses were classified as malignant (n = 136) or benign (n = 32) using a 5-point scale, and this dataset was then randomly divided into five subsets.

As lead AJR author Takashi Tanaka explained: "Four were used for augmentation and supervised training (48,832 images), and one was used for testing (281 images)."

Utilising the Inception-v3 architecture CNN model, the AUC for malignancy and accuracy at optimal cut-off values of output data were evaluated in six different CNN models.

Finding no significant size difference between malignant and benign lesions, Tanaka's team did find that the AUC value of the corticomedullary phase was higher than that of other phases (corticomedullary vs excretory, p = 0.022).

Additionally, the highest accuracy (88%) was achieved in the corticomedullary phase images.

Multivariate analysis revealed that the CNN model of corticomedullary phase was a significant predictor for malignancy, "compared with other CNN models, age, sex, and lesion size," Tanaka concluded.

Source: American Roentgen Ray Society

0

Comments

Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation